Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More General news updates Hinduja family appeals Swiss court verdict on domestic worker exploitation The Hinduja family, prominent business figures, have officially contested a recent Swiss court decision sentencing four family members… byPallavi MadhirajuJune 22, 2024